GOT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.301000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.468400E-01
Normal-vs-Stage2
9.036800E-01
Normal-vs-Stage3
1.781420E-01
Normal-vs-Stage4
5.575000E-01
Stage1-vs-Stage2
9.546600E-01
Stage1-vs-Stage3
1.619610E-01
Stage1-vs-Stage4
4.745600E-01
Stage2-vs-Stage3
4.226400E-02
Stage2-vs-Stage4
2.605400E-01
Stage3-vs-Stage4
1.004180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.151400E-01
Normal-vs-AfricanAmerican
7.146200E-01
Normal-vs-Asian
9.597800E-01
Caucasian-vs-AfricanAmerican
5.024600E-01
Caucasian-vs-Asian
9.040400E-01
AfricanAmerican-vs-Asian
5.623000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.762600E-01
Normal-vs-Female
8.848000E-01
Male-vs-Female
6.499800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.774000E-01
Normal-vs-Age(41-60Yrs)
8.683200E-01
Normal-vs-Age(61-80Yrs)
8.168600E-01
Normal-vs-Age(81-100Yrs)
7.273000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.815800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.881000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.826400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.322040E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.921400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.873180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.052400E-01
Normal-vs-Daily Drinker
5.513400E-01
Normal-vs-Weekly Drinker
6.550400E-01
Normal-vs-Occasional Drinker
6.423200E-01
Normal-vs-Social Drinker
7.186800E-01
Non Drinker-vs-Daily Drinker
9.747800E-01
Non Drinker-vs-Weekly Drinker
7.868800E-01
Non Drinker-vs-Occasional Drinker
5.704400E-02
Non Drinker-vs-Social Drinker
1.087550E-01
Daily Drinker-vs-Weekly Drinker
7.538600E-01
Daily Drinker-vs-Occasional Drinker
4.915700E-02
Daily Drinker-vs-Social Drinker
8.898200E-02
Weekly Drinker-vs-Occasional Drinker
1.272410E-01
Weekly Drinker-vs-Social Drinker
1.876180E-01
Occasional Drinker-vs-Social Drinker
8.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.480000E-02
Normal-vs-Grade 2
2.026100E-02
Normal-vs-Grade 3
3.454200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.834800E-01
Grade 1-vs-Grade 3
4.156000E-01
Grade 1-vs-Grade 4
9.480000E-02
Grade 2-vs-Grade 3
2.891200E-01
Grade 2-vs-Grade 4
2.026100E-02
Grade 3-vs-Grade 4
3.454200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.288200E-01
Normal-vs-NonDiabetic
9.653400E-01
Diabetic-vs-NonDiabetic
2.444400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.781600E-01
Normal-vs-NoPancreatitis
8.758000E-01
Pancreatitis-vs-NoPancreatitis
7.194800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.647200E-01
Normal-vs-N1
8.733600E-01
N0-vs-N1
2.585600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.432600E-01
Normal-vs-TP53-NonMutant
9.455800E-01
TP53-Mutant-vs-TP53-NonMutant
2.549600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
